Circulation, Vol 73, 615-621, Copyright © 1986 by American Heart Association
GJ Hasking, MD Esler, GL Jennings, D Burton, JA Johns and PI Korner
The analysis of plasma kinetics of the sympathetic neurotransmitter
norepinephrine can be used to estimate sympathetic nervous "activity"
(integrated nerve firing rate) for the body as a whole and for individual
organs. In 12 patients with cardiac failure (left ventricular ejection
fraction 10% to 39%), the mean arterial plasma norepinephrine concentration
was 557 +/- 68 pg/ml (mean +/- SE) compared with 211 +/- 21 pg/ml in 15
subjects without heart failure (p less than .002). The difference was due
to both increased release of norepinephrine to plasma (indicating increased
"total" sympathetic activity) and reduced clearance of norepinephrine from
plasma. The increase in sympathetic activity did not involve all organs
equally. Cardiac (32 +/- 9 vs 5 +/- 1 ng/min; p less than .002) and renal
(202 +/- 45 vs 66 +/- 9 ng/min; p = .002) norepinephrine spillover were
increased by 540% and 206%, respectively, but norepinephrine spillover from
the lungs was normal. Adrenomedullary activity was also increased in the
patients with heart failure, whose mean arterial plasma epinephrine
concentration was 181 +/- 38 pg/ml compared with 71 +/- 12 pg/ml in control
subjects (p less than .02). There is marked regional variation, inapparent
from measurements of plasma norepinephrine concentration, in sympathetic
nerve activity in patients with congestive heart failure. The finding of
increased cardiorenal norepinephrine spillover has important
pathophysiologic and therapeutic implications.
ARTICLES
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity
This article has been cited by other articles:
 |
|
 |
|
  M. P. Schlaich, P. A. Sobotka, H. Krum, R. Whitbourn, A. Walton, and M. D. Esler Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept Hypertension, December 1, 2009; 54(6): 1195 - 1201. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, Z. B. Popovic, S. Bibevski, I. Fakhry, D. A. Sica, D. R. Van Wagoner, and T. N. Mazgalev Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model Circ Heart Fail, November 1, 2009; 2(6): 692 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Opie and J. Knuuti The adrenergic-Fatty Acid load in heart failure. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1637 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Berger QT Interval Variability Is It a Measure of Autonomic Activity? J. Am. Coll. Cardiol., August 25, 2009; 54(9): 851 - 852. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ramchandra, S. G. Hood, D. A. Denton, R. L. Woods, M. J. McKinley, R. M. McAllen, and C. N. May Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure PNAS, January 20, 2009; 106(3): 924 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Grassi, G. Bolla, F. Quarti-Trevano, F. Arenare, G. Brambilla, and G. Mancia Sympathetic activation in congestive heart failure: Reproducibility of neuroadrenergic markers Eur J Heart Fail, December 1, 2008; 10(12): 1186 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tsutamoto, K. Nishiyama, H. Sakai, T. Tanaka, M. Fujii, T. Yamamoto, M. Yamaji, and M. Horie Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure Eur J Heart Fail, December 1, 2008; 10(12): 1208 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J Colucci and B. D Berry Heart Failure Worsening and Exacerbation After Venlafaxine and Duloxetine Therapy Ann. Pharmacother., June 1, 2008; 42(6): 882 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kioka, T. Yamada, T. Mine, T. Morita, Y. Tsukamoto, S. Tamaki, M. Masuda, K. Okuda, M. Hori, and M. Fukunami Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart, October 1, 2007; 93(10): 1213 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Q. Trevano, R. Dell'Oro, G. Bolla, C. Cuspidi, F. Arenare, and G. Mancia Neurogenic Abnormalities in Masked Hypertension Hypertension, September 1, 2007; 50(3): 537 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. D. Watson, S. G. Hood, R. Ramchandra, R. M. McAllen, and C. N. May Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H798 - H804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Feng, D. B. Hoover, and N. Paolocci Forever Young?: Nerve Growth Factor, Sympathetic Fibers, and Right Ventricle Pressure Overload Circ. Res., June 22, 2007; 100(12): 1670 - 1672. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Stickland, J. D. Miller, C. A. Smith, and J. A. Dempsey Carotid Chemoreceptor Modulation of Regional Blood Flow Distribution During Exercise in Health and Chronic Heart Failure Circ. Res., May 11, 2007; 100(9): 1371 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, F. Scopelliti, R. Dell'Oro, G. Bolla, and G. Mancia Excessive Sympathetic Activation in Heart Failure With Obesity and Metabolic Syndrome: Characteristics and Mechanisms Hypertension, March 1, 2007; 49(3): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. U. Khand, A. C. Rankin, J. G.F. Cleland, I. Gemmell, E. Clark, and P. W. Macfarlane The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods. Europace, November 1, 2006; 8(11): 927 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Hesayen and J. D. Parker Adverse effects of atrioventricular synchronous right ventricular pacing on left ventricular sympathetic activity, efficiency, and hemodynamic status Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2377 - H2379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Mills, H. Kubo, D. M. Harris, R. M. Berretta, V. Piacentino III, and S. R. Houser Phosphorylation of phospholamban at threonine-17 reduces cardiac adrenergic contractile responsiveness in chronic pressure overload-induced hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H61 - H70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Krum, E. Lambert, E. Windebank, D. J. Campbell, and M. Esler Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1706 - H1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Metra, C. Zani, L. Covolo, S. Nodari, N. Pezzali, U. Gelatti, F. Donato, G. Nardi, and L. D. Cas Role of {beta}1- and {alpha}2c-adrenergic receptor polymorphisms and their combination in heart failure: A case-control study Eur J Heart Fail, March 1, 2006; 8(2): 131 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kreusser, M. Haass, S. J. Buss, S. E. Hardt, S. H. Gerber, R. Kinscherf, H. A. Katus, and J. Backs Injection of Nerve Growth Factor Into Stellate Ganglia Improves Norepinephrine Reuptake Into Failing Hearts Hypertension, February 1, 2006; 47(2): 209 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esler and D. Kaye Sympathetic Nervous System Neuroplasticity Hypertension, February 1, 2006; 47(2): 143 - 144. [Full Text] [PDF]
|
|
|
|
|
|
S. Ohshima, S. Isobe, H. Izawa, M. Nanasato, A. Ando, A. Yamada, K. Yamada, T. S. Kato, K. Obata, A. Noda, et al. Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2061 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Gould, M. Yii, M. D. Esler, J. M. Power, and D. M. Kaye Atrial fibrillation impairs cardiac sympathetic response to baroreceptor unloading in congestive heart failure Eur. Heart J., December 1, 2005; 26(23): 2562 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Floras Atrial fibrillation and cardiac sympathetic reflexes in heart failure Eur. Heart J., December 1, 2005; 26(23): 2490 - 2492. [Full Text] [PDF]
|
|
|
|
|
|
M. Petersson, P. Friberg, G. Lambert, and B. Rundqvist Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure Eur J Heart Fail, October 1, 2005; 7(6): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Castro, J. L. Vukasovic, M. Chiong, G. Diaz-Araya, H. Alcaino, M. Copaja, R. Valenzuela, D. Greig, O. Perez, R. Corbalan, et al. Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure Eur J Heart Fail, October 1, 2005; 7(6): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Ganta, N. Lu, B. G. Helwig, F. Blecha, R. R. Ganta, L. Zheng, C. R. Ross, T. I. Musch, R. J. Fels, and M. J. Kenney Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1683 - H1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Tschakovsky and K. E. Pyke Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function J Appl Physiol, September 1, 2005; 99(3): 1235 - 1237. [Full Text] [PDF]
|
|
|
|
|
|
G. Iaccarino, E. Barbato, E. Cipolletta, V. De Amicis, K. B. Margulies, D. Leosco, B. Trimarco, and W. J. Koch Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure Eur. Heart J., September 1, 2005; 26(17): 1752 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tank, A. Diedrich, E. Szczech, F. C. Luft, and J. Jordan Baroreflex Regulation of Heart Rate and Sympathetic Vasomotor Tone in Women and Men Hypertension, June 1, 2005; 45(6): 1159 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Mann and M. R. Bristow Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond Circulation, May 31, 2005; 111(21): 2837 - 2849. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kaye and M. Esler Sympathetic neuronal regulation of the heart in aging and heart failure Cardiovasc Res, May 1, 2005; 66(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Duncker, D. B. Haitsma, D. A. Liem, P. D. Verdouw, and D. Merkus Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction Cardiovasc Res, March 1, 2005; 65(4): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Siecke and P. A. Insel Clarifying the effects of adrenergic receptor polymorphisms by measuring synaptic parameters J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2016 - 2018. [Full Text] [PDF]
|
|
|
|
|
|
A. Al-Hesayen and J. D. Parker Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure Circulation, June 15, 2004; 109(23): 2862 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. S. Akers and L. A. Cassis Presynaptic modulation of evoked NE release contributes to sympathetic activation after pressure overload Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2151 - H2158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kyuma, T. Nakata, A. Hashimoto, K. Nagao, H. Sasao, T. Takahashi, K. Tsuchihashi, and K. Shimamoto Incremental Prognostic Implications of Brain Natriuretic Peptide, Cardiac Sympathetic Nerve Innervation, and Noncardiac Disorders in Patients with Heart Failure J. Nucl. Med., February 1, 2004; 45(2): 155 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Ocaranza, G. Diaz-Araya, J. E. Carreno, D. Munoz, J. P. Riveros, J. E. Jalil, and S. Lavandero Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H498 - H506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Modesti, G Polidori, I Bertolozzi, S Vanni, and I Cecioni Impairment of cardiopulmonary receptor sensitivity in the early phase of heart failure Heart, January 1, 2004; 90(1): 30 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, F. Quarti-Trevano, R. Dell'Oro, G. Bolla, and G. Mancia Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients Hypertension, November 1, 2003; 42(5): 873 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esler and D. Kaye Is Very High Sympathetic Tone in Heart Failure a Result of Keeping Bad Company? Hypertension, November 1, 2003; 42(5): 870 - 872. [Full Text] [PDF]
|
|
|
|
|
|
S.-T. Li, C. Holmes, I. J. Kopin, and D. S. Goldstein Aging-Related Changes in Cardiac Sympathetic Function in Humans, Assessed by 6-18F-Fluorodopamine PET Scanning J. Nucl. Med., October 1, 2003; 44(10): 1599 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sato, K. Maehara, H. Yaoita, H. Otani, A. Hirosaka, T. Saito, N. Onuki, N. Komatsu, T. Ishihata, and Y. Maruyama Correlation Between Cardiac Norepinephrine Overflow During Exercise and Cardiac 123I-MIBG Uptake in Patients with Chronic Heart Failure J. Nucl. Med., October 1, 2003; 44(10): 1618 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Venugopalan and A. K. Agarwal Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy Eur J Heart Fail, October 1, 2003; 5(5): 655 - 658. [Full Text] [PDF]
|
|
|
|
|
|
P. A Gould, M. D Esler, and D. M Kaye Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure Eur. Heart J., September 2, 2003; 24(18): 1657 - 1662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Okuyama, Y. Miyauchi, A. M. Park, A. Hamabe, S. Zhou, H. Hayashi, M. Miyauchi, C. Omichi, H.-N. Pak, L. A. Brodsky, et al. High resolution mapping of the pulmonary vein and the vein of marshall during induced atrial fibrillation and atrial tachycardia in a canine model of pacing-induced congestive heart failure J. Am. Coll. Cardiol., July 16, 2003; 42(2): 348 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Abidov, R. Hachamovitch, S. W. Hayes, C. K. Ng, I. Cohen, J. D. Friedman, G. Germano, and D. S. Berman Prognostic Impact of Hemodynamic Response to Adenosine in Patients Older Than Age 55 Years Undergoing Vasodilator Stress Myocardial Perfusion Study Circulation, June 17, 2003; 107(23): 2894 - 2899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Solin, D. M. Kaye, P. J. Little, P. Bergin, M. Richardson, and M. T. Naughton Impact of Sleep Apnea on Sympathetic Nervous System Activity in Heart Failure Chest, April 1, 2003; 123(4): 1119 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T M Kolettis, E Psarros, Z S Kyriakides, C S Katsouras, L K Michalis, and D A Sideris Haemodynamic and catecholamine response to simulated ventricular tachycardia in man: effect of baseline left ventricular function Heart, March 1, 2003; 89(3): 306 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A Turner, K. E Porter, W. H.T Smith, H. L White, S. G Ball, and A. J Balmforth Chronic {beta}2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism Cardiovasc Res, March 1, 2003; 57(3): 784 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Badenhorst, D. Veliotes, M. Maseko, O. J. Tsotetsi, R. Brooksbank, A. Naidoo, A. J. Woodiwiss, and G. R. Norton {beta}-Adrenergic Activation Initiates Chamber Dilatation in Concentric Hypertrophy Hypertension, March 1, 2003; 41(3): 499 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aggarwal, M. D. Esler, M. J. Morris, G. Lambert, and D. M. Kaye Regional Sympathetic Effects of Low-Dose Clonidine in Heart Failure Hypertension, March 1, 2003; 41(3): 553 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yamada, T. Shimonagata, M. Fukunami, K. Kumagai, H. Ogita, A. Hirata, M. Asai, N. Makino, H. Kioka, H. Kusuoka, et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study J. Am. Coll. Cardiol., January 15, 2003; 41(2): 231 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldstein, D. Robertson, M. Esler, S. E. Straus, and G. Eisenhofer Dysautonomias: Clinical Disorders of the Autonomic Nervous System Ann Intern Med, November 5, 2002; 137(9): 753 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Lanfranchi and V. K Somers Arterial baroreflex function and cardiovascular variability: interactions and implications Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R815 - R826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Akiyama-Uchida, N. Ashizawa, A. Ohtsuru, S. Seto, T. Tsukazaki, H. Kikuchi, S. Yamashita, and K. Yano Norepinephrine Enhances Fibrosis Mediated by TGF-{beta} in Cardiac Fibroblasts Hypertension, August 1, 2002; 40(2): 148 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.F. Notarius, E.R. Azevedo, J.D. Parker, and J.S. Floras Peak oxygen uptake is not determined by cardiac noradrenaline spillover in heart failure Eur. Heart J., May 2, 2002; 23(10): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Merlet, L. Hittinger, J. L. Dubois-Rande, and A. Castaigne Myocardial Adrenergic Dysinnervation in Dilated Cardiomyopathy: Cornerstone or Epiphenomenon? J. Nucl. Med., April 1, 2002; 43(4): 536 - 539. [Full Text] [PDF]
|
|
|
|
 |
|
 R Ferrara, F Mastrorilli, G Pasanisi, S Censi, N D'aiello, A Fucili, M Valgimigli, and R Ferrari Neurohormonal modulation in chronic heart failure Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D3 - D11. [Abstract] [PDF]
|
|
|
|
|
|
G. Grassi, G. Seravalle, G. Bertinieri, M. L. Stella, C. Turri, and G. Mancia Sympathetic Response to Ventricular Extrasystolic Beats in Hypertension and Heart Failure Hypertension, April 1, 2002; 39(4): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Ogita, T Shimonagata, M Fukunami, K Kumagai, T Yamada, Y Asano, A Hirata, M Asai, H Kusuoka, M Hori, et al. Prognostic significance of cardiac 123I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study Heart, December 1, 2001; 86(6): 656 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. A. Abassi, S. Brodsky, T. Karram, I. Dobkin, J. Winaver, and A. Hoffman Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula Cardiovasc Res, August 15, 2001; 51(3): 567 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gabrielsen, P. Bie, N. H. Holstein-Rathlou, N. J. Christensen, J. Warberg, H. Dige-Petersen, E. Frandsen, S. Galatius, B. Pump, V. B. Sorensen, et al. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R459 - R467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Farrell, C.-C. Wei, J. Tallaj, J. L. Ardell, J. A. Armour, G. R. Hageman, W. E. Bradley, and L. J. Dell'Italia Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H813 - H822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Meszaros, D. Khananshvili, and G. Hart Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H903 - H914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats Hypertension, August 1, 2001; 38(2): 255 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-M. Yee, S. D. Pringle, and A. D. Struthers Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1800 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Acar, P Merlet, L Iserin, D Bonnet, D Sidi, A Syrota, and J Kachaner Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy Heart, June 1, 2001; 85(6): 692 - 696. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Kenney, T. I. Musch, and M. L. Weiss Renal sympathetic nerve regulation to heating is altered in rats with heart failure Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2868 - H2875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, L. Johnston, G. Vaddadi, H. Brunner-LaRocca, G. L. Jennings, and M. D. Esler Mechanisms of Carvedilol Action in Human Congestive Heart Failure Hypertension, May 1, 2001; 37(5): 1216 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aggarwal, M. D. Esler, F. Socratous, and D. M. Kaye Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshida, K. Tanonaka, Y. Miyamoto, T. Abe, M. Takahashi, M. B Anand-Srivastava, and S. Takeo Characterization of cardiac myocyte and tissue {beta}-adrenergic signal transduction in rats with heart failure Cardiovasc Res, April 1, 2001; 50(1): 34 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Linke, N. Schoene, S. Gielen, J.u. Hofer, S. Erbs, G. Schuler, and R. Hambrecht Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training J. Am. Coll. Cardiol., February 1, 2001; 37(2): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Notarius and J. S. Floras Limitations of the use of spectral analysis of heart rate variability for the estimation of cardiac sympathetic activity in heart failure Europace, January 1, 2001; 3(1): 29 - 38. [Abstract] [PDF]
|
|
|
|
|
|
B. L. Leonard, S. C. Malpas, K. M. Denton, A. C. Madden, and R. G. Evans Differential control of intrarenal blood flow during reflex increases in sympathetic nerve activity Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R62 - R68. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R Seals and M. D Esler Human ageing and the sympathoadrenal system J. Physiol., November 1, 2000; 528(3): 407 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. B. Sverrisdottir, B. Rundqvist, G. Johannsson, and M. Elam Sympathetic Neural Burst Amplitude Distribution : A More Specific Indicator of Sympathoexcitation in Human Heart Failure Circulation, October 24, 2000; 102(17): 2076 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gabrielsen, V. B. Sorensen, B. Pump, S. Galatius, R. Videbak, P. Bie, J. Warberg, N. J. Christensen, H. Wroblewski, J. Kastrup, et al. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1931 - H1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shite, E. Dong, H. Kawai, S. Y. Stevens, and C.-S. Liang Selegiline improves cardiac sympathetic terminal function and beta -adrenergic responsiveness in heart failure Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1283 - H1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cice, E. Tagliamonte, L. Ferrara, and A. Iacono Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study Eur. Heart J., August 1, 2000; 21(15): 1259 - 1264. [Abstract] [PDF]
|
|
|
|
|
|
M. Zaugg, W. Xu, E. Lucchinetti, S. A. Shafiq, N. Z. Jamali, and M. A. Q. Siddiqui {beta}-Adrenergic Receptor Subtypes Differentially Affect Apoptosis in Adult Rat Ventricular Myocytes Circulation, July 18, 2000; 102(3): 344 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Azevedo, G. E. Newton, J. S. Floras, and J. D. Parker Reducing Cardiac Filling Pressure Lowers Norepinephrine Spillover in Patients With Chronic Heart Failure Circulation, May 2, 2000; 101(17): 2053 - 2059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, A. Mohan, J. Hagen, E. Dong, J. Armstrong, S. Y. Stevens, and C.-S. Liang Alterations in cardiac adrenergic terminal function and beta -adrenoceptor density in pacing-induced heart failure Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1708 - H1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, G. Vaddadi, S. L. Gruskin, X.-J. Du, and M. D. Esler Reduced Myocardial Nerve Growth Factor Expression in Human and Experimental Heart Failure Circ. Res., April 14, 2000; 86 (7): e80 - e84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Patel, K. Zhang, and P. K. Carmines Norepinephrine turnover in peripheral tissues of rats with heart failure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R556 - R562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Bristow {beta}-Adrenergic Receptor Blockade in Chronic Heart Failure Circulation, February 8, 2000; 101(5): 558 - 569. [Full Text] [PDF]
|
|
|
|
|
|
V. G. Macefield, B. Rundqvist, Y. B. Sverrisdottir, B. G. Wallin, and M. Elam Firing Properties of Single Muscle Vasoconstrictor Neurons in the Sympathoexcitation Associated With Congestive Heart Failure Circulation, October 19, 1999; 100(16): 1708 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Braith, M. A. Welsch, M. S. Feigenbaum, H. A. Kluess, and C. J. Pepine Neuroendocrine activation in heart failure is modified by endurance exercise training J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1170 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, T.-H. M. Fan, E. Dong, R. A. Siddiqui, A. Yatani, S. Y. Stevens, and C.-S. Liang ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1609 - H1617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Mann Mechanisms and Models in Heart Failure : A Combinatorial Approach Circulation, August 31, 1999; 100(9): 999 - 1008. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rostagno, M. Felici, S. Caciolli, G. Olivo, M. Comeglio, G. Galanti, and G. G. N. Serneri Decreased Baroreflex Sensitivity Assessed from Phase IV of Valsalva Maneuver in Mild Congestive Heart Failure Angiology, August 1, 1999; 50(8): 655 - 664. [Abstract] [PDF]
|
|
|
|
|
|
G Grassi and G Mancia Sympathetic overactivity and exercise intolerance in heart failure: a cause-effect relationship Eur. Heart J., June 2, 1999; 20(12): 854 - 855. [PDF]
|
|
|
|
|
|
C.F. Notarius, S. Ando, G.A. Rongen, and J.S. Floras Resting muscle sympathetic nerve activity and peak oxygen uptake in heart failure and normal subjects Eur. Heart J., June 2, 1999; 20(12): 880 - 887. [Abstract] [PDF]
|
|
|
|
|
|
G. E. Newton, E. R. Azevedo, and J. D. Parker Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study Circulation, May 11, 1999; 99(18): 2402 - 2407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Kaye, A. M. Dart, G. L. Jennings, and M. D. Esler Antiadrenergic effect of chronic amiodarone therapy in human heart failure J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1553 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Stanford, P. Salmon, G. Mikhail, D. Gettins, S. Zielinski, and J. R. Pepper Plasma catecholamines, pharmacotherapy and mood of subjects with cardiovascular disorder J Psychopharmacol, May 1, 1999; 13(3): 255 - 260. [Abstract] [PDF]
|
|
|
|
|
|
L. Chen, A. L. Sica, and S. M. Scharf Mechanisms of acute cardiovascular response to periodic apneas in sedated pigs J Appl Physiol, April 1, 1999; 86(4): 1236 - 1246. [Abstract] [Full Text] [PDF]
|
|